- Home
- QCOM vs BMY Comparison
QCOM vs BMY Comparison
Compare QCOM & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QCOM | BMY |
|---|---|---|
| Founded | 1985 | 1887 |
| Country | United States | United States |
| Employees | N/A | 32500 |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.9B | 123.7B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | QCOM | BMY |
|---|---|---|
| Price | $130.50 | $59.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 16 |
| Target Price | ★ $167.35 | $61.81 |
| AVG Volume (30 Days) | 7.8M | ★ 9.6M |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | 2.71% | ★ 4.22% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.78 | N/A |
| Revenue | ★ $44,284,000,000.00 | N/A |
| Revenue This Year | $1.03 | N/A |
| Revenue Next Year | $0.76 | N/A |
| P/E Ratio | $47.26 | ★ $17.26 |
| Revenue Growth | ★ 13.66 | N/A |
| 52 Week Low | $120.80 | $42.52 |
| 52 Week High | $205.55 | $62.89 |
Technical Indicators
Market Signals| Indicator | QCOM | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 32.67 | 47.75 |
| Support Level | N/A | $59.23 |
| Resistance Level | $163.23 | $62.47 |
| Average True Range (ATR) | 3.33 | 1.16 |
| MACD | -0.23 | -0.39 |
| Stochastic Oscillator | 9.49 | 22.56 |
Price Performance
Historical ComparisonAbout QCOM QUALCOMM Incorporated
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.